| Similar Articles |
|---|
 |
BusinessWeek
November 10, 2003
Gene G. Marcial |
Ron Perelman Gives Siga A Boost Ronald Perelman is getting into biowarfare defense. Through his investment vehicle MacAndrews & Forbes, Perelman will invest $10 million in Siga Technologies, a tiny biotech that is developing oral drugs to prevent and treat diseases, including smallpox and anthrax.   |
The Motley Fool
December 9, 2011
David Williamson |
1 Biotech Soars While Another Crashes Cell Therapeutics dilutes shareholders while SIGA squashes fears. |
Salon.com
October 9, 2001
Suzy Hansen |
Plague fears A bioterrorism expert talks about the wicked ways of anthrax and the even deadlier potential scourge of smallpox... |
Chemistry World
March 21, 2012
James Urquhart |
Rediscovered Native American remedy kills poxvirus An extract of the pitcher plant Sarracenia purpurea halted viral replication. |
Bio-IT World
June 15, 2003
Malorye Branca |
A View to a Kill Genomics, bioinformatics, and novel laboratory techniques are converging to boost vaccine research against a new wave of emerging diseases, natural and man-made. Now, will in silico modeling ramp up sufficiently to further speed vaccine discovery? |
Fast Company
February 2002
John Ellis |
The (Life) Science of War Sun Tzu wrote "The Art of War." Now the threat of smallpox and other forms of bioterrorism has unleashed the next generation of conflict. Welcome to the science of war... |
